Why Compliance for Life?
“Dr. Edward C. Rosenow III of the Mayo
Clinic College of Medicine calls compliance
'the sixth vital sign,' as important as
respiration, heart rate, temperature, blood pressure
and pain in evaluating a patient's medical status.
In most cases, the problem revolves around a
failure to take medication as prescribed.
This can mean taking too much of a drug as well
as too little or none at all. The misuse or nonuse
of prescribed medications is estimated to add
nearly $200 billion a year to the cost of medical
care.”
(Reported by Jane Brody,
Just What the Doctor Ordered? Not Exactly, The New
York Times, May 9, 2006)
It took only one month after leaving
the hospital for one out of eight
heart-attack patients to quit taking the
lifesaving drugs prescribed to them, a
study of 1,521 patients found. The heart patients
who stopped taking three proven drugs -- aspirin,
beta blockers and statins -- were three
times more likely to die during the next
year than patients who stayed on the drugs. The
study didn't examine why people stopped taking their
medicine, but the patients who quit were more likely
to be older, single and less educated.
(Impact of Medication Therapy
Discontinuation on Mortality After Myocardial Infarction,
P. Michael Ho, MD, PhD; et al., Archives of Internal
Medicine, Vol 166 No. 17, September 25, 2006, 1842-1847)
For diabetes, the average incremental
drug cost for a 20% increase in drug utilization
is $177 and the associated disease-related medical
cost reduction is $1251, for
a net savings of $1074 per patient (an
average ROI of 7.1:1). For cardiovascular
conditions, the average ROI for a 20% increase in
drug utilization is 4.0:1 (hypertension) and 5.1:1
(hypercholesterolemia)...Although drug
costs are a relatively small fraction of total healthcare
costs for [diabetes, hypertension, and hypercholesterolemia],
they have high leverage - a small increase in drug
costs (associated with improved adherence) can produce
a much larger reduction in medical costs. Because
these benefits derive from improved adherence, greater
attention should be devoted to educating patients
on the value of their drug therapy and motivating
behavior changes that improve adherence.
(Impact of Medication Adherence
on Hospitalization Risk and Healthcare Cost, Sokol,
Michael C. MD, MS; McGuigan, Kimberly A. PhD; et
al. Medical Care, vol 43(6) June 2005 551-530)
|
|